Importance of blood pressure control in patients with diabetes mellitus

Journal of Diabetes and its Complications

Volumn 16, Issue 1, 2002, Pages 87-91

  Katayama, Shigehiro ^a   Inaba, Munemichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INSULIN; NIFEDIPINE; NISOLDIPINE; THIAZIDE DIURETIC AGENT;

ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG CHOICE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS; HUMANS; HYPERTENSION; JAPAN; PRACTICE GUIDELINES;

EID: 0036177516     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00201-X     Document Type: Conference Paper

References (24)

1. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role of reduced skeletal muscle blood flow
2. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT)
3. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
4. Diabetes and decline in heart disease mortality in US adults
5. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial
6. Effects of intensive blood-pressure lowering and acetylsalicylic acid in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial
7. Hypertension in Diabetes Study (HDS): 1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
8. Effect of alpha1-blockade on diminished forearm blood flow in diabetics
9. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
10. Diabetes and cardiovascular disease: the Framingham study
11. Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension
12. Effects of captopril on glucose metabolism. Possible role of augmented postprandial forearm blood flow
13. Effects of the vasodilatory β-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension
14. for the collaborative study group: the effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
15. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy
16. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension
17. Use of enarapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus
18. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
19. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
20. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
21. Endothelinopathy precedes type 2 diabetes
22. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
23. Guidelines for the management of hypertension